Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124999225 | 12499922 | 5 | F | 2016 | 20160805 | 20160627 | 20160822 | EXP | BR-JNJFOC-20160620034 | JANSSEN | 0.00 | A | F | Y | 0.00000 | 20160822 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124999225 | 12499922 | 1 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | UNKNOWN | 0 | 600 | MG | LYOPHILIZED POWDER | ||||||
| 124999225 | 12499922 | 2 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | UNKNOWN | 0 | 600 | MG | LYOPHILIZED POWDER | ||||||
| 124999225 | 12499922 | 3 | PS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | UNKNOWN | 103772 | 600 | MG | LYOPHILIZED POWDER | ||||||
| 124999225 | 12499922 | 4 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 124999225 | 12499922 | 5 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 0 | 30 | MG | UNSPECIFIED | ||||||||
| 124999225 | 12499922 | 6 | C | MESALAZINE | MESALAMINE | 1 | Unknown | 0 | 100 | MG | UNSPECIFIED | ||||||||
| 124999225 | 12499922 | 7 | C | GLIFAGE | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 124999225 | 12499922 | 8 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 124999225 | 12499922 | 9 | C | SIMVASTATINE | SIMVASTATIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 124999225 | 12499922 | 10 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 124999225 | 12499922 | 11 | C | GLIBENCLAMIDE | GLYBURIDE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124999225 | 12499922 | 1 | Crohn's disease |
| 124999225 | 12499922 | 2 | Crohn's disease |
| 124999225 | 12499922 | 3 | Crohn's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124999225 | 12499922 | HO |
| 124999225 | 12499922 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124999225 | 12499922 | Back pain | |
| 124999225 | 12499922 | Blood glucose fluctuation | |
| 124999225 | 12499922 | Crohn's disease | |
| 124999225 | 12499922 | Decreased immune responsiveness | |
| 124999225 | 12499922 | Memory impairment | |
| 124999225 | 12499922 | Pneumonia | |
| 124999225 | 12499922 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124999225 | 12499922 | 1 | 20160309 | 0 | ||
| 124999225 | 12499922 | 2 | 20160419 | 0 | ||
| 124999225 | 12499922 | 3 | 2016 | 0 |